ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,426,835 | -24.3% | 164,750 | +0.4% | 2.19% | -15.1% |
| Q2 2023 | $5,850,026 | +46.9% | 164,050 | +4.6% | 2.58% | +26.3% |
| Q1 2023 | $3,982,976 | -36.9% | 156,810 | +0.8% | 2.04% | -43.4% |
| Q4 2022 | $6,311,951 | +21.9% | 155,620 | -0.6% | 3.60% | +13.8% |
| Q3 2022 | $5,176,000 | -4.3% | 156,620 | +2.0% | 3.17% | -2.7% |
| Q2 2022 | $5,409,000 | -21.7% | 153,620 | +2.3% | 3.26% | +0.9% |
| Q1 2022 | $6,909,000 | -28.6% | 150,220 | +2.9% | 3.22% | -19.7% |
| Q4 2021 | $9,677,000 | – | 145,960 | – | 4.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |